We are live on
!
Find out more
Vanguard Portfolio Management Portfolio holdings
AUM
$2.22T
This Fund
S&P 500
This Quarter
Est. Return
+25.71%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.22T
AUM Growth
+$305B
(+16%)
Cap. Flow
+$19.5B
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
21.57%
Holding
3,286
New
192
Increased
2,077
Reduced
864
Closed
145
Avg Time Held
0.9
quarters
Top 10 Avg Time Held
0.8
quarters
Top 20 Avg Time Held
0.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$1.74B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$1.66B |
| 3 |
NVIDIA
NVDA
|
+$1.58B |
| 4 |
Micron Technology
MU
|
+$1.23B |
| 5 |
Devon Energy
DVN
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$2.45B |
| 2 |
Seagate
STX
|
+$2.36B |
| 3 |
Western Digital
WDC
|
+$1.98B |
| 4 |
Honeywell
HON
|
+$1.74B |
| 5 |
Corning
GLW
|
+$1.7B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.19% |
| 2 | Financials | 11.67% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 9.73% |
| 5 | Consumer Discretionary | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2326
ASP Isotopes
ASPI
$434M
| $6.94M | ﹤0.01% |
1,115,391
+138,221
| +14% | +$813K |
2026 Q1
1 quarter
|
|
|
OPTU
2327
Optimum Communications Inc
OPTU
$376M
| $6.93M | ﹤0.01% |
4,776,118
-4,650,526
| -49% | -$5.78M |
2026 Q1
1 quarter
|
|
2328
Vanda Pharmaceuticals
VNDA
$274M
| $6.92M | ﹤0.01% |
1,131,034
+116,512
| +11% | +$761K |
2026 Q1
1 quarter
|
|
2329
Mesa Laboratories
MLAB
$705M
| $6.9M | ﹤0.01% |
69,350
+16,764
| +32% | +$1.69M |
2026 Q1
1 quarter
|
|
2330
Shore Bancshares
SHBI
$754M
| $6.88M | ﹤0.01% |
299,794
+51,020
| +21% | +$1.04M |
2026 Q1
1 quarter
|
|
2331
Teekay
TK
$1.35B
| $6.84M | ﹤0.01% |
684,280
+265,782
| +64% | +$3.33M |
2026 Q1
1 quarter
|
|
2332
Intrepid Potash
IPI
$445M
| $6.84M | ﹤0.01% |
208,551
+14,338
| +7% | +$545K |
2026 Q1
1 quarter
|
|
2333
Oric Pharmaceuticals
ORIC
$1.25B
| $6.81M | ﹤0.01% |
628,682
+57,991
| +10% | +$526K |
2026 Q1
1 quarter
|
|
2334
Hippo Holdings
HIPO
$903M
| $6.78M | ﹤0.01% |
239,837
+15,491
| +7% | +$412K |
2026 Q1
1 quarter
|
|
2335
Willis Lease Finance
WLFC
$846M
| $6.77M | ﹤0.01% |
88,827
+22,704
| +34% | +$1.48M |
2026 Q1
1 quarter
|
|
|
AEVA
2336
Aeva Technologies
AEVA
$954M
| $6.76M | ﹤0.01% |
235,344
-42,503
| -15% | -$836K |
2026 Q1
1 quarter
|
|
2337
Zumiez
ZUMZ
$218M
| $6.75M | ﹤0.01% |
379,400
+13,238
| +4% | +$296K |
2026 Q1
1 quarter
|
|
2338
Mid Penn Bancorp
MPB
$916M
| $6.73M | ﹤0.01% |
193,233
+34,393
| +22% | +$1.14M |
2026 Q1
1 quarter
|
|
2339
B&G Foods
BGS
$213M
| $6.72M | ﹤0.01% |
1,687,409
+30,846
| +2% | +$143K |
2026 Q1
1 quarter
|
|
2340
Lightpath Technologies
LPTH
$682M
| $6.71M | ﹤0.01% |
+410,412
| New | +$5.73M |
2026 Q2
0 quarters
|
|
|
TBPH
2341
DELISTED
Theravance Biopharma
TBPH
| $6.7M | ﹤0.01% |
394,158
-6,601
| -2% | -$109K |
2026 Q1
1 quarter
|
|
2342
Maravai LifeSciences
MRVI
$1.07B
| $6.69M | ﹤0.01% |
1,071,536
+118,698
| +12% | +$512K |
2026 Q1
1 quarter
|
|
2343
Spire Global
SPIR
$406M
| $6.67M | ﹤0.01% |
358,545
+185,112
| +107% | +$3.44M |
2026 Q1
1 quarter
|
|
|
PURR
2344
Hyperliquid Strategies Inc
PURR
$2.24B
| $6.64M | ﹤0.01% |
+843,172
| New | +$6.24M |
2026 Q2
0 quarters
|
|
2345
Five Star Bancorp
FSBC
$1.05B
| $6.61M | ﹤0.01% |
135,768
+17,574
| +15% | +$741K |
2026 Q1
1 quarter
|
|
2346
Sharplink Inc
SBET
$1.91B
| $6.58M | ﹤0.01% |
1,371,582
+1,260,595
| +1,136% | +$8.06M |
2026 Q1
1 quarter
|
|
2347
Shattuck Labs
STTK
$568M
| $6.57M | ﹤0.01% |
+946,985
| New | +$5.91M |
2026 Q2
0 quarters
|
|
2348
Sana Biotechnology
SANA
$835M
| $6.57M | ﹤0.01% |
1,881,689
+174,168
| +10% | +$561K |
2026 Q1
1 quarter
|
|
2349
CytomX Therapeutics
CTMX
$538M
| $6.57M | ﹤0.01% |
1,751,167
+956,412
| +120% | +$3.65M |
2026 Q1
1 quarter
|
|
2350
Orion
OEC
$329M
| $6.57M | ﹤0.01% |
990,393
+104,017
| +12% | +$748K |
2026 Q1
1 quarter
|
|
Similar funds
Vanguard Portfolio Management's Q2 2026 Portfolio in Review
As of Q2 2026, Vanguard Portfolio Management held 3,286 positions worth $2.22T, up 16% from $1.91T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Vanguard Portfolio Management's Q2 2026 filing shows 192 new, 2,077 increased, 864 reduced and 145 closed positions. Its largest new stake was SpaceX: 10,225,389 shares worth $1.75B. The largest sale was Marvell Technology, an estimated $2.45B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 29% a quarter earlier, followed by Financials and Industrials.
- Vanguard Portfolio Management's largest Q2 2026 buy was SpaceX: 10,225,389 shares worth $1.75B.
- Vanguard Portfolio Management added most to NVIDIA in Q2 2026, an estimated $1.58B increase.
- Vanguard Portfolio Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $2.45B.
- Vanguard Portfolio Management fully exited Coterra Energy in Q2 2026, selling an estimated $1.3B.
- Vanguard Portfolio Management's ten largest holdings make up 22% of its $2.22T portfolio in Q2 2026.
- Vanguard Portfolio Management opened 192 new positions and closed 145 in Q2 2026.
- Vanguard Portfolio Management's portfolio value rose 16% quarter-over-quarter to $2.22T.
Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.